hydroxyindoleacetic acid has been researched along with Down Syndrome in 34 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Down Syndrome: A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (91.18) | 18.7374 |
1990's | 2 (5.88) | 18.2507 |
2000's | 1 (2.94) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Taşdemir, HA | 1 |
Cetinkaya, MC | 1 |
Polat, C | 1 |
Belet, U | 1 |
Kalayci, AG | 1 |
Akbaş, S | 1 |
Seidl, R | 1 |
Kaehler, ST | 1 |
Prast, H | 1 |
Singewald, N | 1 |
Cairns, N | 1 |
Gratzer, M | 1 |
Lubec, G | 1 |
Ternaux, JP | 1 |
Mattei, JF | 1 |
Faudon, M | 1 |
Barrit, MC | 1 |
Ardissone, JP | 1 |
Giraud, F | 1 |
Tu, JB | 1 |
Wong, CY | 1 |
Komatsu, H | 1 |
Nishimura, A | 1 |
Okano, S | 1 |
Miyanomae, Y | 1 |
Takeuchi, Y | 1 |
Sawada, T | 1 |
Kay, AD | 2 |
Schapiro, MB | 2 |
Riker, AK | 1 |
Haxby, JV | 2 |
Rapoport, SI | 2 |
Cutler, NR | 1 |
Godridge, H | 1 |
Reynolds, GP | 1 |
Czudek, C | 1 |
Calcutt, NA | 1 |
Benton, M | 1 |
May, C | 1 |
Ryker, AK | 1 |
Kaufman, S | 1 |
Milstien, S | 1 |
Adlard, BP | 1 |
De Souza, SW | 1 |
Tricklebank, MD | 1 |
Bettschart, W | 2 |
Broché, JP | 1 |
Tissot, R | 2 |
Guggisberg, M | 1 |
Constantinidis, J | 1 |
Paulson, GW | 2 |
Nance, W | 1 |
Son, C | 1 |
Pare, CM | 1 |
Son, CD | 1 |
Nance, WE | 1 |
Dubowitz, V | 2 |
Rogers, K | 1 |
Rogers, KJ | 1 |
Coleman, M | 1 |
Benson, PF | 1 |
Southgate, J | 1 |
Partington, MW | 2 |
MacDonald, MR | 1 |
Gordon, EK | 2 |
Oliver, J | 1 |
Tu, J | 1 |
Lott, IT | 1 |
Murphy, DL | 1 |
Chase, TN | 3 |
Papeschi, R | 1 |
Molina-Negro, P | 1 |
Sourkes, TL | 1 |
Erba, G | 1 |
Chiancone, FM | 1 |
Andersson, H | 1 |
Fällström, SP | 1 |
Lundborg, P | 1 |
Roos, BE | 1 |
Boullin, DJ | 1 |
O'Brien, RA | 1 |
Ng, LK | 1 |
Burger, PC | 1 |
Vogel, FS | 1 |
Airaksinen, EM | 2 |
Kauko, K | 1 |
Weise, P | 1 |
Koch, R | 1 |
Shaw, KN | 1 |
Rosenfeld, MJ | 1 |
Kamoun, P | 1 |
Lafourcade, G | 1 |
Jerome, H | 1 |
Bazelon, M | 1 |
Barnet, A | 1 |
Lodge, A | 1 |
Shelburne, SA | 1 |
1 review available for hydroxyindoleacetic acid and Down Syndrome
Article | Year |
---|---|
Serotonergic mechanisms and extrapyramidal function in man.
Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extr | 1974 |
3 trials available for hydroxyindoleacetic acid and Down Syndrome
Article | Year |
---|---|
[Correlation of the clinical and pharmaco-dynamic effects of Niamid in the treatment of severely mentally retarded children].
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Child; Clinical Trials as Topic; Down Syndrome; Female; Huma | 1965 |
5-hydroxytryptophan (5-HTP) in Down's syndrome.
Topics: 5-Hydroxytryptophan; Child; Child, Preschool; Clinical Trials as Topic; Down Syndrome; Female; Human | 1971 |
Platelet-rich plasma 5-hydroxytryptamine, urinary 5-hydroxyindoleacetic acid and tryptophan ingestion in mongols.
Topics: Adolescent; Adult; Blood Platelets; Blood Specimen Collection; Child; Child, Preschool; Chromosome A | 1971 |
30 other studies available for hydroxyindoleacetic acid and Down Syndrome
Article | Year |
---|---|
Gallbladder motility in children with Down syndrome.
Topics: Case-Control Studies; Child, Preschool; Confidence Intervals; Down Syndrome; Female; Gallbladder; Ga | 2004 |
Serotonin (5-HT) in brains of adult patients with Down syndrome.
Topics: Adult; Alzheimer Disease; Brain; Caudate Nucleus; Cerebellum; Chromatography, High Pressure Liquid; | 1999 |
Peripheral and central 5-hydroxytryptamine in trisomy 21.
Topics: Adolescent; Albumins; Child; Down Syndrome; Fatty Acids, Nonesterified; Female; Humans; Hydroxyindol | 1979 |
Serotonin metabolism in normal and abnormal infants during the perinatal period.
Topics: Amniotic Fluid; Down Syndrome; Female; Fetal Blood; Humans; Hydroxyindoleacetic Acid; Infant, Newbor | 1976 |
Neuroleptic malignant syndrome-like state in a patient with Down syndrome and basal ganglia calcification.
Topics: Adolescent; Basal Ganglia Diseases; Calcinosis; Down Syndrome; Homovanillic Acid; Humans; Hydroxyind | 1992 |
Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Catecholamines; Down Syndrome; Female; Homovanillic Aci | 1987 |
Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
Topics: Acetylcholine; Adult; Age Factors; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Dopamine; | 1987 |
Cerebrospinal fluid monoamines in Down's syndrome adults at different ages.
Topics: Adult; Age Factors; Amines; Biopterins; Catecholamines; Cognition; Dementia; Down Syndrome; Female; | 1987 |
Letter: 5-hydroxyindoleacetic acid in Down's syndrome.
Topics: Blood Cell Count; Blood Platelets; Child, Preschool; Chromosomes, Human, 21-22 and Y; Down Syndrome; | 1974 |
[Urinary excretion of 5-hydroxyindoleacetic acid, vanillomandelic acid and xanthurenic acid in 18 Mongoloids].
Topics: Down Syndrome; Humans; Hydroxyindoleacetic Acid; In Vitro Techniques; Mandelic Acids; Xanthurenates | 1966 |
Neurologic aspects of typical and atypical Down's syndrome.
Topics: Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Down Syndrome; Electroencepha | 1968 |
5-hydroxyindoles in phenylketonuric and nonphenylketonuric mental defectives.
Topics: 5-Hydroxytryptophan; Animals; Biological Transport; Carboxy-Lyases; Child; Down Syndrome; Humans; Hy | 1968 |
Neurologic aspects of typical and atypical Down's syndrome.
Topics: Cataract; Chromosome Aberrations; Down Syndrome; Gait; Humans; Hydroxyindoleacetic Acid; Intelligenc | 1969 |
5-Hydroxyindoles in mongolism and hydrocephalus.
Topics: Down Syndrome; Humans; Hydrocephalus; Hydroxyindoleacetic Acid; Infant; Serotonin | 1969 |
5-hydroxyindoles in the cerebrospinal fluid of infants with Down's syndrome and muscle hypotonia.
Topics: Child; Child, Preschool; Down Syndrome; Female; Humans; Hydroxyindoleacetic Acid; Infant; Intellectu | 1969 |
5-HIAA in cerebrospinal fluid.
Topics: Down Syndrome; Humans; Hydroxyindoleacetic Acid; Serotonin | 1970 |
Diminished activity of platelet monoamine oxidase in Down's syndrome.
Topics: Blood Platelets; Child; Child, Preschool; Down Syndrome; Female; Humans; Hydroxyindoleacetic Acid; I | 1971 |
3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid.
Topics: Chromatography, Gas; Depression; Dihydroxyphenylalanine; Down Syndrome; Ethers; Glycols; Humans; Hyd | 1971 |
5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation.
Topics: Adolescent; Adult; Child; Child, Preschool; Down Syndrome; Female; Humans; Hydroxyindoleacetic Acid; | 1972 |
Down's syndrome. Central monoamine turnover in patients with diminished platelet serotonin.
Topics: Adolescent; Adult; Blood Platelets; Child; Down Syndrome; Female; Humans; Hydroxyindoleacetic Acid; | 1972 |
The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Cerebral Palsy; Cerebral Ventricles; Diazepam; Dihydroxyp | 1972 |
[Functional exploration at various levels of the tryptophan--nicotinic acid metabolic line].
Topics: Diabetes Mellitus; Down Syndrome; Female; Humans; Hydroxyindoleacetic Acid; Hydroxylation; Kynurenin | 1972 |
5-hydroxyindoleacetic acid in children with Down's syndrome.
Topics: Age Factors; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, 21-22 and Y; Down Syndrom | 1973 |
The metabolism of 5-hydroxytryptamine by blood platelets from children with mongolism.
Topics: 5-Hydroxytryptophan; Blood Platelets; Child; Child, Preschool; Chromatography, Paper; Down Syndrome; | 1973 |
Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Carbon Radioisotopes; Cerebrospinal Fluid; Child; | 1973 |
The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.
Topics: Adolescent; Adult; Aged; Autopsy; Brain; Brain Chemistry; Child; Child, Preschool; Dementia; Down Sy | 1973 |
Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.
Topics: Administration, Oral; Adolescent; Child; Chromatography, Gel; Depression, Chemical; Down Syndrome; F | 1973 |
The use of 5-HTP in the treatment of Down's syndrome.
Topics: 5-Hydroxytryptophan; Administration, Oral; Age Factors; Child Development; Child, Preschool; Chromat | 1974 |
Catabolism of serotonin in Down's syndrome (tisomy 21).
Topics: Blood Platelets; Carbon Radioisotopes; Child; Down Syndrome; Humans; Hydroxyindoleacetic Acid; Monoa | 1974 |
The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations.
Topics: 5-Hydroxytryptophan; Age Factors; Central Nervous System; Chromosomes, Human, 21-22 and Y; Down Synd | 1968 |